- Public Comps
- HTG Molecular Diagnostics
HTG Molecular Diagnostics Valuation Multiples
Discover revenue and EBITDA valuation multiples for HTG Molecular Diagnostics and similar public comparables like Strata Skin Sciences, Lipella Pharmaceuticals, ViewRay, Acutus Medical and more.
HTG Molecular Diagnostics Overview
About HTG Molecular Diagnostics
HTG Molecular Diagnostics Inc is a life science company whose mission is to advance precision medicine through its transcriptome-wide profiling and medicinal chemistry technologies. The company derives revenue from sales of its HTG EdgeSeq system and integrated next-generation sequencing-based HTG EdgeSeq research use only assays and from sample processing services performed in its VERI/O laboratory. The company operates in one segment and its customers and distributors are located in the United States and Europe.
Founded
1997
HQ

Employees
54
Website
Financials (FY)
Market Cap
$0K
Valuation Multiples
Start free trialHTG Molecular Diagnostics Financials
HTG Molecular Diagnostics reported last fiscal year revenue of $6M and negative EBITDA of ($20M).
In the same fiscal year, HTG Molecular Diagnostics generated $2M in gross profit, ($20M) in EBITDA losses, and had net loss of ($22M).
HTG Molecular Diagnostics P&L
In the most recent fiscal year, HTG Molecular Diagnostics reported revenue of $6M and EBITDA of ($20M).
HTG Molecular Diagnostics is unprofitable as of last fiscal year, with gross margin of 28%, EBITDA margin of (316%), and net margin of (339%).
Financial data powered by Morningstar, Inc.
HTG Molecular Diagnostics Stock Performance
HTG Molecular Diagnostics has current market cap of $0K.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $0K | - | - | - | - | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHTG Molecular Diagnostics Valuation Multiples
HTG Molecular Diagnostics trades at (0.4x) EV/Revenue multiple, and 0.1x EV/EBITDA.
HTG Molecular Diagnostics Financial Valuation Multiples
As of August 14, 2026, HTG Molecular Diagnostics has market cap of $0K.
HTG Molecular Diagnostics has a P/E ratio of 0.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HTG Molecular Diagnostics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


HTG Molecular Diagnostics Margins & Growth Rates
In the most recent fiscal year, HTG Molecular Diagnostics reported gross margin of 28%, EBITDA margin of (316%), and net margin of (339%).
HTG Molecular Diagnostics Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
HTG Molecular Diagnostics Operational KPIs
HTG Molecular Diagnostics' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.4M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
HTG Molecular Diagnostics Competitors
HTG Molecular Diagnostics competitors include Strata Skin Sciences, Lipella Pharmaceuticals, ViewRay, Acutus Medical, Viveve Medical, Evome Medical, Remedent and Easton Pharmaceuticals.
Most HTG Molecular Diagnostics public comparables operate across Life Sciences Tools, Diagnostics & Genomics, Medical Devices, BioTech and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.3x | - | 47.2x | - | |||
| (3.0x) | - | 0.3x | - | |||
| 0.0x | - | (0.0x) | - | |||
| 1.1x | - | 9.7x | - | |||
| 0.0x | - | (0.0x) | - | |||
| 0.3x | - | (1.9x) | - | |||
This data is available for Pro users. Sign up to see all HTG Molecular Diagnostics competitors and their valuation data. Start Free Trial | ||||||
HTG Molecular Diagnostics VC Funding History
Before going public, HTG Molecular Diagnostics raised $8M in total equity funding, across 1 round.
HTG Molecular Diagnostics Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HTG Molecular Diagnostics
| When was HTG Molecular Diagnostics founded? | HTG Molecular Diagnostics was founded in 1997. |
| Where is HTG Molecular Diagnostics headquartered? | HTG Molecular Diagnostics is headquartered in United States. |
| How many employees does HTG Molecular Diagnostics have? | As of today, HTG Molecular Diagnostics has over 54 employees. |
| Is HTG Molecular Diagnostics publicly listed? | Yes, HTG Molecular Diagnostics is a public company listed on OTCM. |
| What is the stock symbol of HTG Molecular Diagnostics? | HTG Molecular Diagnostics trades under HTGMQ ticker. |
| When did HTG Molecular Diagnostics go public? | HTG Molecular Diagnostics went public in 2015. |
| Who are competitors of HTG Molecular Diagnostics? | HTG Molecular Diagnostics main competitors include Strata Skin Sciences, Lipella Pharmaceuticals, ViewRay, Acutus Medical, Viveve Medical, Evome Medical, Remedent, Easton Pharmaceuticals. |
| What is the current market cap of HTG Molecular Diagnostics? | HTG Molecular Diagnostics' current market cap is $0K. |
| What is the current revenue of HTG Molecular Diagnostics? | HTG Molecular Diagnostics' last fiscal year revenue is $6M. |
| What is the current EV/Revenue multiple of HTG Molecular Diagnostics? | Current revenue multiple of HTG Molecular Diagnostics is (0.4x). |
| Is HTG Molecular Diagnostics profitable? | No, HTG Molecular Diagnostics is not profitable. |
| How many companies HTG Molecular Diagnostics has acquired to date? | HTG Molecular Diagnostics hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies HTG Molecular Diagnostics has invested to date? | HTG Molecular Diagnostics hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to HTG Molecular Diagnostics
Lists including HTG Molecular Diagnostics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




